Cargando…

Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

Detalles Bibliográficos
Autores principales:	Gharebaghi, Naser, Nejadrahim, Rahim, Mousavi, Seyed Jalil, Sadat-Ebrahimi, Seyyed-Reza, Hajizadeh, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689645/ https://www.ncbi.nlm.nih.gov/pubmed/33243191 http://dx.doi.org/10.1186/s12879-020-05628-w

Ejemplares similares

The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
por: Gharebaghi, Naser, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report
por: Nejadrahim, Rahim, et al.
Publicado: (2021)

Role of MicroRNAs in Diagnosis, Prognosis, and Treatment of Acute Heart Failure: Ambassadors from Intracellular Zone
por: Sadat-Ebrahimi, Seyyed-Reza, et al.
Publicado: (2020)

The association between T wave inversion in leads with ST-elevation and patency of the infarct-related artery
por: Ranjbar, Abdolmohammad, et al.
Publicado: (2021)

A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

P182 Mucormycosis in Northwest Iranian cases with a history of delta COVID-19, a brief report
por: Diba, Kambiz, et al.
Publicado: (2022)

Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
por: Danieli, Maria Giovanna, et al.
Publicado: (2021)

Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
por: Sakoulas, George, et al.
Publicado: (2020)

Palpation by blind examiners: A novel approach for glaucoma screening
por: Heidary, Fatemeh, et al.
Publicado: (2010)

12: AN EVIDENCE-BASED REVIEW REGARDING OFF-LABEL PRESCRIPTIONS OF POLIDOCANOL
por: Ebrahimi, Seyyed Reza Sadat
Publicado: (2017)

Effect of saffron on liver metastases in patients suffering from cancers with liver metastases: A randomized, double blind, placebo-controlled clinical trial
por: Hosseini, Azar, et al.
Publicado: (2015)

Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in chronic inflammatory demyelinating polyradiculoneuropathy: protocol of an international, randomised, double-blind, placebo-controlled trial (OPTIC)
por: Bus, S. R. M., et al.
Publicado: (2021)

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
por: Yamada, Hideto, et al.
Publicado: (2022)

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
por: Cao, Wei, et al.
Publicado: (2020)

Effect of beetroot or beetroot plus vitamin C supplementation on cardiovascular function in patients with coronary artery disease: protocol for a double-blind, placebo-controlled, randomised trial
por: Bahrami, Leila Sadat, et al.
Publicado: (2022)

Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial
por: Miyasaka, Nobuyuki, et al.
Publicado: (2011)

The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
por: Maleki, Vahid, et al.
Publicado: (2020)

Impact of Early Treatment With High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children
por: Karimi Yazdi, Alireza, et al.
Publicado: (2021)

Comparison of early and late intravenous gamma globulin treatment of Kawasaki disease on fever and cardiovascular complications
por: Mohammadzadeh, Iraj, et al.
Publicado: (2016)

A double-blind, placebo-controlled trial of Fennel (Foeniculum vulgare) on menopausal symptoms: A high placebo response
por: Ghazanfarpour, Masumeh, et al.
Publicado: (2018)

Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)
por: Lennox, Belinda, et al.
Publicado: (2019)

Author's reply – Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
por: Yamada, Hideto, et al.
Publicado: (2022)

Comparing the Therapeutic Effectiveness of N-acetylcysteine with the Combination of N-acetyl Cysteine and Cimetidine in Acute Acetaminophen Toxicity: A Double-Blinded Clinical Trial
por: Ebrahimi, Mohsen, et al.
Publicado: (2015)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

The Effect of Cytotoxicity and Antimicrobial of Synthesized CuO NPs from Propolis on HEK-293 Cells and Lactobacillus acidophilus
por: Seyyed Hajizadeh, Yasamin, et al.
Publicado: (2023)

Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
por: Aslani, Nahid, et al.
Publicado: (2022)

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
por: Davey, Richard T, et al.
Publicado: (2019)

INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY
por: Dhar, Sandipan
Publicado: (2009)

High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
por: Erdogan, Cem, et al.
Publicado: (2020)

Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
por: Suzuki, Yasuhito, et al.
Publicado: (2020)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

Effect of Intravenous Acetaminophen on Postoperative Pain in Vitrectomy: A Randomized, Double-Blind, Clinical Trial
por: Sadrolsadat, Seyed Hossein, et al.
Publicado: (2017)

Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study
por: Kahbazi, Manijeh, et al.
Publicado: (2016)

Baclofen for maintenance treatment of opioid dependence: A randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]
por: Assadi, Seyed Mohammad, et al.
Publicado: (2003)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
por: Dubée, Vincent, et al.
Publicado: (2021)

A case of pheochromocytoma presenting with cardiac manifestation: case report
por: Molaei, Akbar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ve12dj8t6amdnl8qs8ml2oqmr8